Cancer Research
Hidden Metabolic Loop Lets Liver Cancer Dodge Immunotherapy
A newly discovered enzyme-driven feedback cycle helps liver tumors suppress immunity and resist checkpoint blockade — and blocking it may help.
Research Paper
Jul 4, 2026 0
Cancer
675 articles in this topic
Cancer Research
Oxford Calculator Shows 98% of Statin Candidates Face Low Muscle Risk
A new Oxford tool using 5.6 million patient records shows serious statin muscle side effects are rare, yet 60% of eligible patients skip the drug.
Press Release
Jul 3, 2026 0
Cancer Research
IDH1 Mutant Brain Tumor Vaccine Shows Remarkable 8-Year Survival in Phase 1 Trial
A neoantigen peptide vaccine targeting IDH1-R132H mutation doubled median survival in grade IV astrocytoma patients vs. historical benchmarks.
Research Paper
Jul 3, 2026 0
Cancer Research
Thyroid Cancer Subtypes Decoded From Molecular Drivers to Targeted Cures
A comprehensive review maps the distinct molecular mechanisms and emerging therapies across all four thyroid cancer subtypes.
Research Paper
Jul 2, 2026 0
Cancer Research
Degarelix vs Goserelin Head-to-Head in Advanced Prostate Cancer
Phase 3 trial pits next-gen GnRH antagonist degarelix against standard goserelin in prostate cancer hormone suppression.
Clinical Trial
Jul 2, 2026 0
Cancer Research
Senescent Non-Cancer Cells Inside Tumors Are Reshaping Cancer Outcomes
A new review reveals how senescent healthy cells within tumors quietly drive cancer progression and therapy resistance.
Review
Jul 2, 2026 0
Cancer Research
Accelerated Biological Aging May Drive the Surge in Early-Onset Cancer
New research links faster biological aging in younger adults to the alarming rise in cancers before age 50.
Research Paper
Jul 2, 2026 0
Cancer Research
Abraxane Plus Pembrolizumab Targets Advanced Bladder Cancer in Cisplatin-Ineligible Patients
A completed phase 2 trial tested nab-paclitaxel combined with the checkpoint inhibitor pembrolizumab in patients with advanced urothelial cancer who cannot tolerate cisplatin.
Clinical Trial
Jul 1, 2026 0
Cancer Research
Low-Dose Gut Radiation Revives Immune Checkpoint Therapy in Drug-Resistant Cancers
A phase II trial tests whether 1Gy intestinal radiation can re-sensitize solid tumors that have stopped responding to immunotherapy.
Clinical Trial
Jul 1, 2026 0
Cancer Research
USC Scientists Grow Endless Cancer-Fighting Immune Cells From Self-Renewing Precursors
USC researchers unlocked a scalable supply of engineered immune-cell precursors that fight tumors and may revolutionize cancer immunotherapy.
Press Release
Jun 30, 2026 0
Cancer Research
New Compounds Force Pancreatic Cancer Cells to Self-Destruct by Overloading Their Own Signals
Experimental PCAI compounds blocked over 90% of pancreatic cancer cell migration and triggered self-destruction by hyperactivating tumor growth pathways.
Press Release
Jun 30, 2026 0
Cancer Research
Bevacizumab Added to Chemo Tested in Children With Metastatic Sarcoma
A Phase 2 trial examines whether adding the anti-angiogenic drug bevacizumab to standard chemo improves outcomes in pediatric sarcoma.
Clinical Trial
Jun 30, 2026 0